| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |